Available by prescription only, Pertzye® (pancrelipase) is a medication used to treat pancreatic enzyme deficiencies. It is approved for use in people who have cystic fibrosis or other conditions that cause these deficiencies.
This drug comes as a delayed-release capsule that is taken with every snack and meal. It is approved for use in adults and children as young as 12 months old. Side effects are possible and may include heartburn, diarrhea, and a cough.
Before starting treatment with Pertzye, your healthcare provider will need information on your medical history and any other medications, vitamins, or supplements you are taking. He or she will also ask if you are pregnant or breastfeeding and whether you have any problems with your bowels or kidneys.
(For more details on this medication, click Pertzye. This full-length article presents more information, including dosing instructions, potential side effects, and important safety warnings.)
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: ArthurSchoenstadt, MD
List of references (click here):
Pertzye [package insert]. Bethlehem, PA: Digestive Care, Inc.;2012 May.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed January 10, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click